羚锐制药(600285.SH)：董事、副总经理陈燕拟减持不超20万股股份

Core Viewpoint - The company, Lingrui Pharmaceutical (600285.SH), announced that its Vice President, Ms. Chen Yan, plans to reduce her shareholding due to personal financial needs, with a maximum reduction of 200,000 shares, representing 0.0353% of the total share capital and up to 25% of her total holdings [1] Summary by Relevant Sections - Share Reduction Plan - Ms. Chen Yan intends to sell up to 200,000 shares through centralized bidding within three months after the disclosure of the reduction plan, excluding the trading window period [1] - The selling price will be determined based on the market price at the time of the reduction [1]